Please assess the completion status of the following clinical trial:

Trial Title: Physiological Flow of Liquids Used in Dysphagia Management (Neuro)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adults (18+) with a confirmed diagnosis of Amyotrophic Lateral Sclerosis (ALS) or Parkinson's disease (PD)~Exclusion Criteria:~* People with a prior medical history of stroke~* People with a prior medical history of acquired brain injury~* People with a prior medical history of spinal or spinal cord injury~* People with a prior medical history of cancer or surgery in the head and neck region~* People who have had radiation to the head and neck for cancer~* People who have a prior history of swallowing problems (e.g., from childhood, medical complication)~* People with significant breathing difficulties (e.g., rely on mechanical ventilation)~* People who rely solely on tube-feeding for all meals and nutrition~* People who have Type I (insulin-dependent) Diabetes~* Women who are pregnant~* People who have allergies to barium, potato starch, corn starch, xanthan gum, milk products, latex or dental glue

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Amyotrophic Lateral Sclerosis (Type: None): We will be recruiting individuals with confirmed or probably ALS, who experience speech or swallowing problems, to attend one data collection session. All participants will undergo the same protocol, including a Videofluoroscopic Swallowing Examination, and Tongue Strength Measurement.
- Parkinson's Disease (Type: None): We will be recruiting individuals with a diagnosis of Parkinson's disease, who experience speech or swallowing problems, to attend one data collection session. All participants will undergo the same protocol, including a Videofluoroscopic Swallowing Examination, and Tongue Strength Measurement.

Based on this trial design, predict the completion outcome and termination type (if applicable).